Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Datos de investigación Set de datos (Dataset)

Acute Gluten-Induced Inflammatory Protein Signature in Celiac Disease: A Step Towards Biomarker Discovery, Firma proteica inflamatoria inducida agudamente por el gluten en la enfermedad celíaca: un paso hacia el descubrimiento de biomarcadores

  • Gómez Aguililla, Sara
  • Farrais Villalba, Sergio
  • López Palacios, Natalia
  • Arau, Beatriz
  • Senosiain, Carla
  • Infante Menéndez, Jorge
  • Ruiz Carnicer, Ángela
  • Fernández Bañares, Fernando
  • González López, Nuria
  • Pujals, Mar
  • Sousa, Carolina
  • Núñez Pardo de Vera, María Concepción
Relative concentrations of 74 inflammation-related serum proteins obtained by proximity extension assay (PEA, Olink) in patients with celiac disease and in non-celiac controls. Measurements were obtained while participants were on a gluten-free diet (≥1 month) at two time points: baseline (on GFD) and 4 hours after a single gluten challenge (10 g). NA indicates values below the limit of quantification., Background Diagnosis of celiac disease (CD) remains challenging in individuals already on a gluten-free diet (GFD). Although several alternative methods have been proposed, they have limitations. Identifying inflammation-related proteins that rapidly respond to gluten exposure in blood may offer diagnostic alternatives. Objective To characterize the inflammatory protein response to gluten in patients with CD on a GFD, and to assess the diagnostic potential of candidate biomarkers and their association with clinical symptoms. Methods Seventeen patients with CD and 15 non-CD individuals on a GFD (≥ 1 month) consumed 10 g of gluten. Serum, plasma and clinical symptoms were collected at baseline and 4 h post-gluten ingestion to assess changes in 92 inflammation-related proteins. Results Following gluten consumption, 18 proteins changed significantly only in patients with CD. Six showed an AUC ≥80%, and CCL20 achieved 85.7% sensitivity and 92.7% specificity for CD diagnosis. CCL20 level increases post-gluten challenge were higher in patients with vomiting but were also observed in those with absent or mild symptoms. Conclusion Gluten reintroduction triggers alterations in the inflammation-related protein profile of patients with CD. CCL20 emerges as a promising diagnostic candidate, its increase in plasma or serum, with low dependence on symptom presentation, may complement existing diagnostic approaches., Base de datos